pLenti- V6.3 Ultra Citations (2)

Originally described in: CMV eGFP-P2A-T2A, blasticidin selectable
Snaar-Jagalska Unpublished

Articles Citing pLenti- V6.3 Ultra

Articles
Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization. Heitzer E, Groenewoud A, Meditz K, Lohberger B, Liegl-Atzwanger B, Prokesch A, Kashofer K, Behrens D, Haybaeck J, Kolb-Lenz D, Koefeler H, Riedl S, Schaider H, Fischer C, Snaar-Jagalska BE, de'Jong D, Szuhai K, Zweytick D, Rinner B. Sci Rep. 2019 Mar 11;9(1):4096. doi: 10.1038/s41598-019-40570-1. PubMed Associated Plasmids pLenti- V6.3 lox-dsRED-stop-lox-eGFP-blas
The PROTECTOR strategy employs dCas orthologs to sterically shield off-target sites from CRISPR/Cas activity. Sapozhnikov DM, Szyf M. Sci Rep. 2023 Feb 9;13(1):2280. doi: 10.1038/s41598-023-29332-2. PubMed Associated Plasmids pLenti-Sa-gRNA-puro pLenti-eGFP-dSaCas9-blast pLenti-dSaCas9-KRAB-blast

If you have published an article using this material, please email us at [email protected] to have your article added to this page.